Several studies have reported that CFTR dysfunction is associated with the development and progression of esophageal cancers, both esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), and all studies support a tumor suppressing role for CFTR. This evidence concerns the gene CFTR and esophageal adenocarcinoma.